Role of Stereotactic Radiosurgery in the Younger Population

1999 ◽  
pp. 262-269
Author(s):  
R. Smee ◽  
B. Kwok ◽  
M. Schneider ◽  
M. Vonau
Keyword(s):  
Stereotactic Radiosurgery

Role of Stereotactic Radiosurgery in the Management of Brain and Spine Metastases

2018 ◽  
Vol 14 (1) ◽  
pp. 55-67
Author(s):  
Jacob A. Miller ◽  
Ehsan H. Balagamwala ◽  
Samuel T. Chao
Keyword(s):  
Stereotactic Radiosurgery ◽  
Spine Metastases

The Evolving Role of Stereotactic Radiosurgery and Stereotactic Radiation Therapy for Patients with Spine Tumors

2004 ◽  
Vol 69 (1-3) ◽  
pp. 319-334 ◽  
Author(s):  
Jack P. Rock ◽  
Samuel Ryu ◽  
Fang-Fang Yin ◽  
Faye Schreiber ◽  
Muwaffak Abdulhak
Keyword(s):  
Radiation Therapy ◽  
Stereotactic Radiosurgery ◽  
Stereotactic Radiation Therapy ◽  
Stereotactic Radiation ◽  
Spine Tumors

Role of Stereotactic Radiosurgery in the Management of Pineal Parenchymal Tumors

2009 ◽  
pp. 44-58 ◽  
Author(s):  
Hideyuki Kano ◽  
Ajay Niranjan ◽  
Douglas Kondziolka ◽  
John C. Flickinger ◽  
Dade Lunsford
Keyword(s):  
Stereotactic Radiosurgery ◽  
Pineal Parenchymal Tumors

scholarly journals The role of radiosurgery for hemangiopericytomas

2003 ◽  
Vol 14 (5) ◽  
pp. 1-5 ◽  
Author(s):  
Steven D. Chang ◽  
Gordon T. Sakamoto
Keyword(s):  
Stereotactic Radiosurgery ◽  
Distant Metastases ◽  
Residual Tumor ◽  
High Rate ◽  
Tumor Control ◽  
Small Subset ◽  
Patient Database ◽  
The Mean

Object Hemangiopericytomas represent a small subset of meningeal tumors. Despite their relatively uncommon nature, they are aggressive tumors known for recurrence. Resection is the standard treatment in most, although regrowth and metastases are common even after resection. The authors evaluate the role of stereotactic radiosurgery in the treatment of recurrent hemangiopericytomas. Methods In a review of the Stanford radiosurgery patient database between 1989 and 2002, the authors found eight patients with recurrent hemangiopericytoma who underwent stereotactic radiosurgery. The mean age of this population was 45.1 years (range 24–67 years). All patients had been previously treated with resection, and five patients (63%) had undergone conventional radiotherapy. The mean radiosurgery dose to the tumor margin was 20.5 Gy (range 16–24 Gy). The mean clinical and radiographic follow-up period was 44 months (range 8–77 months). Of the eight tumors treated with radiosurgery, six decreased in size and two ultimately progressed. There were no radiosurgery-related complications. Conclusions Stereotactic radiosurgery of hemangiopericytomas can result in increased tumor control and should be considered as a treatment option for patients in whom the diagnosis has been established and in whom residual tumor is demonstrated postoperatively. Close clinical and radiographic follow-up evaluation is necessary in this patient population because of the high rate of local recurrence and distant metastases.

Advances in Radiosurgery for Arteriovenous Malformations of the Brain

Neurosurgery ◽  
2014 ◽  
Vol 74 (suppl_1) ◽  
pp. S50-S59 ◽  
Author(s):  
Benjamin A. Rubin ◽  
Andrew Brunswick ◽  
Howard Riina ◽  
Douglas Kondziolka
Keyword(s):  
Natural History ◽  
Stereotactic Radiosurgery ◽  
Endovascular Therapy ◽  
Arteriovenous Malformations ◽  
Morbidity And Mortality ◽  
Cerebral Arteriovenous Malformations ◽  
History Of ◽  
The Brain ◽  
Management Algorithms

Abstract Arteriovenous malformations of the brain are a considerable source of morbidity and mortality for patients who harbor them. Although our understanding of this disease has improved, it remains in evolution. Advances in our ability to treat these malformations and the modes by which we address them have also improved substantially. However, the variety of patient clinical and disease scenarios often leads us into challenging and complex management algorithms as we balance the risks of treatment against the natural history of the disease. The goal of this article is to provide a focused review of the natural history of cerebral arteriovenous malformations, to examine the role of stereotactic radiosurgery, to discuss the role of endovascular therapy as it relates to stereotactic radiosurgery, and to look toward future advances.

scholarly journals Hearing loss after radiosurgery-blame it on Cochlear dose or the radiation tool!

2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Harsh Deora ◽  
Manjul Tripathi
Keyword(s):  
Hearing Loss ◽  
Stereotactic Radiosurgery ◽  
Recent Article ◽  
Sudden Hearing Loss ◽  
Dosing Regimen ◽  
New Therapies ◽  
Unexpected Outcome

Abstract While sudden hearing loss after stereotactic radiosurgery has been demonstrated in some cases a recent article by Linge et al. and have demonstrated the need for further discussion on this topic. We attempt to delineate the fact that the type of dosing regimen or technology used will not affect the hearing or radio-graphical control outcomes and thus should not be a consideration while administering treatment. Also we discuss the role of location of the lesion and vascularity and potential new therapies for this unexpected outcome after radiosurgery.

Sign in / Sign up

Export Citation Format

Share Document